News Detail
NEW DELHI, 23 NOV 2024: Abbott, the global healthcare company announced the launch of AVEIR™ VR single-chamber ventricular leadless pacemaker for the treatment of patients in India with slow heart rhythms. This pacemaker is now approved by Central Drugs Standard Contr......
View Details
Source : Abbott India
Cardiac electrophysiology
Embedded systems
Prosthetics
Neuroprosthetics
Medical devices
Artificial cardiac pacemaker
Cardiology
Abbott Laboratories
Clinical cardiac electrophysiology
Government Administration Activities
Hospitals
Clinics & Primary Care Services
Balbir Singh
Taiwan
Vanita Arora
Ajay Singh Chauhan
Chairman Cardiology
Max Superspeciality Hospital
electricity
chest incision
General Manager
India
US FOOD AND DRUG ADMINISTRATION
US Food and Drug Administration
Apollo Hospitals
Southeast Asia
Central Drugs Standard Control Organisation
Abbott
Related News
- Liver infection Patient in JLN given expired medicine (25-11-2024)
- Beware of Fake Combiart Tablets, NAFDAC Alerts Nigerians (25-11-2024)
- FSSAI notifies norms prescribing limits for crop contaminants, prohibiting vet drugs (25-11-2024)
- Centre to amend Rules to grant manufacturing license for stem cell derived & gene therapy products (25-11-2024)
- Rampant use of steroid creams may cause fungal infection: Doctors (25-11-2024)
- 2 Held In Jabalpur With ₹7.5 Lakh Worth Of Illegal Drugs (25-11-2024)
- Delhi NCB team seized 24 thousand tablets in Jodhpur from a parcel in bus (25-11-2024)
- Ayurvedic doctor booked for high antibiotic dosage to pregnant woman (24-11-2024)
- Food Safety Task Force raids nutraceutical manufacturing units in IDA Mallapur (24-11-2024)
- Campaign against quacks in Pratapgarh district (24-11-2024)